AU Stock MarketDetailed Quotes
CHM Chimeric Therapeutics Ltd
- 0.006
- 0.0000.00%
20min DelayMarket Closed Jan 10 16:00 AET
9.45MMarket Cap-0.33P/E (Static)
0.006High0.006Low2.54MVolume0.006Open0.006Pre Close15.26KTurnover0.03952wk High0.39%Turnover Ratio1.58BShares0.00652wk Low-0.018EPS TTM3.91MFloat Cap0.440Historical HighLossP/E (Static)651.97MShs Float0.006Historical Low-0.018EPS LYR0.00%Amplitude--Dividend TTM3.00P/B1Lot Size--Div YieldTTM
About Chimeric Therapeutics Ltd Company
Chimeric Therapeutics Ltd is a biotechnology company engaged in developing a cancer cell therapy drug. Its technology CLTX-CAR T uses chlorotoxin, a peptide discovered in scorpion venom, as the tumor-targeting component of the CAR to reprogram T cells. Primary products under development by the company are NK Cell Derived Allogenic Therapies and T Cell Derived Autologous Therapies. The company has one segment being the research, development and commercialization of health technologies.
Company Profile
SymbolCHM
Company NameChimeric Therapeutics Ltd
Founded2020
MarketASX
Fiscal Year Ends06-30
Address62 Lygon Street Level 3, Carlton South
CityMelbourne
CountryAustralia
Zip Code3053
Phone+61 398245254
Share RegistryBOARDROOM PTY LIMITED
LEVEL 8, 210 GEORGE STREET, SYDNEY, NSW, AUSTRALIA, 2000
(02) 9290 9600
Company Executives
- Name
- Position
- Salary
- Paul Alex Hopper
- Founder,Executive Chairman,Executive Director
- --
- Phillip Hains
- Chief Financial Officer,Joint Company Secretary,Non Executive Director
- --
- Lesley Russell
- Non-Executive Director
- --
- Eric Sullivan
- Non-Executive Director
- --
Heat List
AU
Overall
Symbol
Price
% Chg
No Data